The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Stephenson Brian C since 2019.
This trader's CIK number is 1780030.
At the time of last reporting, Stephenson Brian C was the Secretary, Treasurer & CFO of Bridgebio Pharma, Inc.. (stock ticker symbol BBIO).
Also see all insider trading activities at Bridgebio Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | BBIO | 0 | $0 | 72,148 | $2,617,763 | 93,798 | $1,156,000 |
| 2024 | BBIO | 0 | $0 | 8,311 | $196,004 | 98,300 | $0 |
| 2023 | BBIO | 0 | $0 | 392,710 | $5,484,495 | 162,613 | $0 |
| 2022 | BBIO | 0 | $0 | 19,678 | $184,992 | 86,315 | $0 |
| 2021 | BBIO | 8,000 | $500,000 | 0 | $0 | 9,173 | $0 |
| 2020 | BBIO | 0 | $0 | 82,800 | $2,571,648 | 3,419 | $0 |
| 2019 | BBIO | 55,500 | $943,500 | 0 | $0 | 312,946 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-16 | BBIO | Option Ex | 25,798 | .00 | 0 |
| 2025-02-19 | BBIO | Sale | 4,148 | 36.16 | 149,975 |
| 2025-01-28 | BBIO | Option Ex | 68,000 | 17.00 | 1,156,000 |
| 2025-01-28 | BBIO | Sale | 68,000 | 36.29 | 2,467,788 |
| 2024-11-19 | BBIO | Sale | 4,156 | 22.41 | 93,135 |
| 2024-08-16 | BBIO | Option Ex | 25,797 | .00 | 0 |
| 2024-08-19 | BBIO | Sale | 4,155 | 24.76 | 102,869 |
| 2024-05-16 | BBIO | Option Ex | 27,507 | .00 | 0 |
| 2024-02-16 | BBIO | Option Ex | 44,996 | .00 | 0 |
| 2023-11-17 | BBIO | Sale | 22,685 | 29.10 | 660,065 |
| 2023-11-16 | BBIO | Option Ex | 44,996 | .00 | 0 |
| 2023-08-17 | BBIO | Sale | 22,683 | 28.59 | 648,461 |
| 2023-08-16 | BBIO | Option Ex | 44,994 | .00 | 0 |
| 2023-05-16 | BBIO | Option Ex | 44,996 | .00 | 0 |
| 2023-05-17 | BBIO | Sale | 24,424 | 14.01 | 342,180 |
| 2023-05-03 | BBIO | Sale | 64,929 | 14.18 | 920,693 |
| 2023-04-05 | BBIO | Sale | 55,500 | 15.45 | 857,697 |
| 2023-03-03 | BBIO | Sale | 62,692 | 10.96 | 687,167 |
| 2023-02-17 | BBIO | Sale | 17,717 | 12.86 | 227,822 |
| 2023-02-16 | BBIO | Option Ex | 27,627 | .00 | 0 |
| 2023-02-03 | BBIO | Sale | 61,040 | 11.01 | 671,928 |
| 2023-01-05 | BBIO | Sale | 61,040 | 7.67 | 468,482 |
| 2022-11-17 | BBIO | Sale | 19,678 | 9.40 | 184,992 |
| 2022-11-16 | BBIO | Option Ex | 30,467 | .00 | 0 |
| 2022-08-16 | BBIO | Option Ex | 26,680 | .00 | 0 |
| 2022-05-16 | BBIO | Option Ex | 26,680 | .00 | 0 |
| 2022-02-16 | BBIO | Option Ex | 2,488 | .00 | 0 |
| 2021-11-16 | BBIO | Option Ex | 2,488 | .00 | 0 |
| 2021-08-16 | BBIO | Option Ex | 2,487 | .00 | 0 |
| 2021-05-16 | BBIO | Option Ex | 2,488 | .00 | 0 |
| 2021-02-17 | BBIO | Buy | 8,000 | 62.50 | 500,000 |
| 2021-02-16 | BBIO | Option Ex | 1,710 | .00 | 0 |
| 2020-11-16 | BBIO | Option Ex | 1,710 | .00 | 0 |
| 2020-08-16 | BBIO | Option Ex | 1,709 | .00 | 0 |
| 2020-08-03 | BBIO | Sale | 4,661 | 27.76 | 129,380 |
| 2020-08-04 | BBIO | Sale | 2,539 | 27.37 | 69,492 |
| 2020-07-01 | BBIO | Sale | 10,800 | 31.61 | 341,344 |
| 2020-06-08 | BBIO | Sale | 2,000 | 30.00 | 60,002 |
| 2020-06-03 | BBIO | Sale | 1,600 | 30.05 | 48,072 |
| 2020-06-01 | BBIO | Sale | 7,200 | 29.52 | 212,580 |
| 2020-05-05 | BBIO | Sale | 5,706 | 30.49 | 173,958 |
| 2020-05-01 | BBIO | Sale | 7,200 | 29.47 | 212,191 |
| 2020-05-04 | BBIO | Sale | 1,494 | 30.00 | 44,827 |
| 2020-04-01 | BBIO | Sale | 7,200 | 26.87 | 193,456 |
| 2020-03-02 | BBIO | Sale | 10,800 | 32.58 | 351,896 |
| 2020-02-04 | BBIO | Sale | 4,973 | 34.52 | 171,692 |
| 2020-02-03 | BBIO | Sale | 5,827 | 34.90 | 203,379 |
| 2020-01-02 | BBIO | Sale | 7,164 | 33.86 | 242,573 |
| 2020-01-03 | BBIO | Sale | 3,636 | 32.12 | 116,806 |
| 2019-07-01 | BBIO | Buy | 55,500 | 17.00 | 943,500 |
| 2019-07-01 | BBIO | Option Ex | 312,946 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stephenson Brian C (Secretary, Treasurer & CFO of Bridgebio Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.